IL99759A - Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them - Google Patents
Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL99759A IL99759A IL99759A IL9975991A IL99759A IL 99759 A IL99759 A IL 99759A IL 99759 A IL99759 A IL 99759A IL 9975991 A IL9975991 A IL 9975991A IL 99759 A IL99759 A IL 99759A
- Authority
- IL
- Israel
- Prior art keywords
- aminoindan
- propargyl
- mono
- preparation
- pharmaceutical compositions
- Prior art date
Links
- RUOKEQAAGRXIBM-UHFFFAOYSA-N n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical class C1=CC=C2C(NCC#C)CCC2=C1 RUOKEQAAGRXIBM-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- REMZONJIIBEOHN-UHFFFAOYSA-N 4-fluoro-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound FC1=CC=CC2=C1CCC2NCC#C REMZONJIIBEOHN-UHFFFAOYSA-N 0.000 abstract 1
- RAWRWXXSRQSLRX-UHFFFAOYSA-N 5-fluoro-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound FC1=CC=C2C(NCC#C)CCC2=C1 RAWRWXXSRQSLRX-UHFFFAOYSA-N 0.000 abstract 1
- SJGUUGICXKISGE-UHFFFAOYSA-N 6-fluoro-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound FC1=CC=C2CCC(NCC#C)C2=C1 SJGUUGICXKISGE-UHFFFAOYSA-N 0.000 abstract 1
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract 1
- 108010062431 Monoamine oxidase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11281991A IL112819A (en) | 1991-10-16 | 1991-10-16 | Fluorinated 1-aminoindan compounds and a process for their preparation |
| IL99759A IL99759A (en) | 1991-10-16 | 1991-10-16 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
| AU26063/92A AU649565B2 (en) | 1991-10-16 | 1992-09-30 | Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
| ZA927570A ZA927570B (en) | 1991-10-16 | 1992-10-01 | Mono-fluorinated derivatives of N-propagyl-1-aminoindan and their use as inhibitors of monoamine oxidase. |
| FI924458A FI113262B (fi) | 1991-10-16 | 1992-10-02 | Menetelmä N-propargyyli-1-aminoindaanin fluorattujen johdannaisten valmistamiseksi |
| NZ244616A NZ244616A (en) | 1991-10-16 | 1992-10-05 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, preparation and pharmaceutical compositions thereof |
| HU9203162A HU217589B (hu) | 1991-10-16 | 1992-10-06 | N-propargil-1-amino-indán monofluorszármazékai és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek és a gyógyászati készítmények előállítására |
| CA002079968A CA2079968C (en) | 1991-10-16 | 1992-10-06 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
| CN92113070A CN1038928C (zh) | 1991-10-16 | 1992-10-14 | 制备单氟化的n-炔丙基-1-氨基茚满衍生物的方法 |
| AT92402821T ATE149999T1 (de) | 1991-10-16 | 1992-10-15 | Monofluorierte derivate von n-propargyl-1- aminoindan und deren verwendung als monoamino- oxidaseinhibitoren |
| DK92402821.0T DK0538134T3 (da) | 1991-10-16 | 1992-10-15 | Monofluorerede derivater af N-propargyl-1-aminoindan og deres anvendelse som inhibitorer for monoaminoxidase |
| ES92402821T ES2101063T3 (es) | 1991-10-16 | 1992-10-15 | Derivados monofluorados de n-propargil-1-amino-indano y su utilizacion como inhibidores de la monoamin-oxidasa. |
| EP92402821A EP0538134B1 (de) | 1991-10-16 | 1992-10-15 | Monofluorierte Derivate von N-Propargyl-1-Aminoindan und deren Verwendung als Monoamino-Oxidaseinhibitoren |
| JP27731492A JP3247165B2 (ja) | 1991-10-16 | 1992-10-15 | N−プロパルギル−1−アミノインダンのモノ−弗素化誘導体、これを有効成分とする薬剤およびその製造方法 |
| DE69218101T DE69218101T2 (de) | 1991-10-16 | 1992-10-15 | Monofluorierte Derivate von N-Propargyl-1-Aminoindan und deren Verwendung als Monoamino-Oxidaseinhibitoren |
| US08/310,480 US5486541A (en) | 1991-10-16 | 1994-09-22 | Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
| GR970401207T GR3023556T3 (en) | 1991-10-16 | 1997-05-26 | Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL99759A IL99759A (en) | 1991-10-16 | 1991-10-16 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL99759A0 IL99759A0 (en) | 1992-08-18 |
| IL99759A true IL99759A (en) | 1997-06-10 |
Family
ID=11062970
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL99759A IL99759A (en) | 1991-10-16 | 1991-10-16 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
| IL11281991A IL112819A (en) | 1991-10-16 | 1991-10-16 | Fluorinated 1-aminoindan compounds and a process for their preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11281991A IL112819A (en) | 1991-10-16 | 1991-10-16 | Fluorinated 1-aminoindan compounds and a process for their preparation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5486541A (de) |
| EP (1) | EP0538134B1 (de) |
| JP (1) | JP3247165B2 (de) |
| CN (1) | CN1038928C (de) |
| AT (1) | ATE149999T1 (de) |
| AU (1) | AU649565B2 (de) |
| CA (1) | CA2079968C (de) |
| DE (1) | DE69218101T2 (de) |
| DK (1) | DK0538134T3 (de) |
| ES (1) | ES2101063T3 (de) |
| FI (1) | FI113262B (de) |
| GR (1) | GR3023556T3 (de) |
| HU (1) | HU217589B (de) |
| IL (2) | IL99759A (de) |
| NZ (1) | NZ244616A (de) |
| ZA (1) | ZA927570B (de) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744500A (en) | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| ES2139750T3 (es) * | 1993-08-06 | 2000-02-16 | Upjohn Co | 2-aminoindanos como ligandos selectivos d3 de la dopamina. |
| IL111240A (en) * | 1993-10-18 | 2001-10-31 | Teva Pharma | Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them |
| EP0738149B1 (de) * | 1994-01-10 | 2006-11-29 | Teva Pharmaceutical Industries, Ltd. | 1-aminoindanderivate und zusammensetzungen hiervon |
| US5914349A (en) | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
| IL118836A (en) * | 1996-07-11 | 2001-01-11 | Teva Pharma | Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan |
| US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| US6191166B1 (en) * | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| CA2275425C (en) | 1996-12-18 | 2009-08-04 | Michael Chorev | Aminoindan derivatives |
| US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| GB9715082D0 (en) * | 1997-07-17 | 1997-09-24 | Scherer Ltd R P | Treatment of attention deficit hyperactivity disorder and narcolepsy |
| US6569851B1 (en) * | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| JP2003512426A (ja) | 1999-10-27 | 2003-04-02 | テバ ファーマシューティカル インダストリーズ リミティド | 双極性気分障害における躁病の治療のための1−アミノインダンの使用。 |
| WO2001083425A1 (en) * | 2000-05-04 | 2001-11-08 | Warner-Lambert Company | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| TWI290549B (en) * | 2000-06-02 | 2007-12-01 | Astrazeneca Ab | Process for the preparation of cyclopropyl carboxylic acid ester and derivatives |
| US20020151526A1 (en) * | 2000-10-06 | 2002-10-17 | Gallop Mark A. | Bile-acid prodrugs of L-dopa and their use in the sustained treatment of parkinsonism |
| US6956129B2 (en) * | 2001-02-16 | 2005-10-18 | Bayer Aktiengesellschaft | Polyhalogen-substituted cinnamic acids and cinnamic acid derivatives and a process for the preparation of polyhalogen-substituted cinnamic acids and cinnamic acid derivatives |
| US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| SI1567152T1 (sl) * | 2002-11-15 | 2013-10-30 | Teva Pharmaceutical Industries Ltd. | Uporaba rasagilina z riluzolom za zdravljenje amiotrofične lateralne skleroze |
| US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| US8097608B2 (en) | 2003-11-25 | 2012-01-17 | Technion Research And Development Foundation Ltd. | Methods for treatment of cardiovascular disorders and diseases |
| US20080090915A1 (en) * | 2003-11-25 | 2008-04-17 | Technion Research And Development Foundation Ltd. | Method for preventing or attenuating anthracycline-induced cardiotoxicity |
| EP2433626B1 (de) | 2003-11-25 | 2015-11-04 | Technion Research & Development Foundation Ltd. | Zusammensetzungen und Verfahren zur Behandlung kardiovaskulärer Erkrankungen |
| US20060018957A1 (en) * | 2004-07-26 | 2006-01-26 | Lerner E I | Pharmaceutical dosage forms including rasagiline |
| US20060025446A1 (en) * | 2004-07-27 | 2006-02-02 | Jeffrey Sterling | Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders |
| RS52867B (sr) * | 2005-02-17 | 2013-12-31 | Teva Pharmaceutical Industries Ltd. | Kombinovana terapija glatiramer acetatom i razagilinom za lečenje multiple skleroze |
| US20100167983A1 (en) * | 2007-10-22 | 2010-07-01 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| US7815942B2 (en) | 2005-02-23 | 2010-10-19 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
| NZ564130A (en) * | 2005-06-02 | 2009-12-24 | Jenrin Discovery | N-propargyl-1-aminoindan compounds useful for treating obesity |
| US8263655B2 (en) * | 2005-10-06 | 2012-09-11 | Technion Research And Development Foundation Ltd | Methods for treatment of renal failure |
| US7491847B2 (en) | 2005-11-17 | 2009-02-17 | Teva Pharmaceutical Industries, Ltd. | Methods for isolating propargylated aminoindans |
| US7572834B1 (en) | 2005-12-06 | 2009-08-11 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations and processes for their preparation |
| JP2009518433A (ja) | 2005-12-09 | 2009-05-07 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム | 神経保護用の低用量ラドスチギルの使用 |
| US8809310B2 (en) | 2006-02-21 | 2014-08-19 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of multiple system atrophy |
| TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
| AU2007235517B2 (en) | 2006-04-03 | 2013-01-31 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of Restless Legs Syndrome |
| EP1892233A1 (de) * | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
| AU2007334428B2 (en) * | 2006-12-14 | 2014-05-29 | Teva Pharmaceutical Industries, Ltd. | Crystalline solid rasagiline base |
| UA97382C2 (ru) * | 2006-12-14 | 2012-02-10 | Тева Фармасьютікл Індастріз, Лтд. | Таннат разагилина |
| EP1987816A1 (de) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff |
| US20090062400A1 (en) * | 2007-09-05 | 2009-03-05 | Laurence Oron | Method of treating glaucoma using rasagiline |
| US8188149B2 (en) * | 2007-09-17 | 2012-05-29 | Teva Pharmaceutical Industries, Ltd. | Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss |
| EP2053033A1 (de) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Verbindungen zur Verwendung bei der Abbildung, Diagnose und/oder Behandlung von Erkrankungen des zentralen Nervensystems oder von Tumoren |
| EA201070842A1 (ru) * | 2008-01-11 | 2011-04-29 | Тева Фармасьютикал Индастриз, Лтд. | Препаративные формы разагилина, их получение и применение |
| AU2009258120B2 (en) * | 2008-06-10 | 2014-11-27 | Teva Pharmaceutical Industries, Ltd. | Rasagiline soft gelatin capsules |
| EP2296462A4 (de) * | 2008-06-13 | 2011-06-15 | Teva Pharma | Rasagilin zur beeinflussung von morbus parkinson |
| NZ589547A (en) | 2008-06-19 | 2013-03-28 | Teva Pharma | Dried rasagiline base having a water content less than 0.5 % by weight |
| JP2011525489A (ja) * | 2008-06-19 | 2011-09-22 | テバ ファーマシューティカル インダストリーズ リミティド | ラサリジン塩基の精製方法 |
| ES2402765T3 (es) * | 2008-12-22 | 2013-05-08 | Krka, D.D., Novo Mesto | Procedimiento de preparación de ivabradina |
| US20100189790A1 (en) * | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline formulation |
| PT2451771E (pt) | 2009-07-09 | 2014-09-19 | Ratiopharm Gmbh | Sais de rasagilina e suas preparações farmacêuticas |
| WO2011087791A1 (en) * | 2009-12-22 | 2011-07-21 | Teva Pharmaceutical Industries Ltd. | 3-keto-n-propargyl-1-aminoindan |
| US9943489B2 (en) | 2010-02-03 | 2018-04-17 | Pharmatwob Ltd. | Extended release formulations of rasagiline and uses thereof |
| RU2587330C2 (ru) | 2010-07-27 | 2016-06-20 | Тева Фармасьютикал Индастриз Лтд. | Применение разагилина для лечения обонятельной дисфункции |
| WO2012015946A1 (en) | 2010-07-27 | 2012-02-02 | Teva Pharmaceutical Industries Ltd. | Dispersion of rasagiline citrate |
| BR112014008555A2 (pt) | 2011-10-10 | 2017-04-18 | Teva Pharma | r(+)-n-formil-propargil-aminoindano |
| CA2851433A1 (en) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | R(+)-n-methyl-propargyl-aminoindan |
| AR092168A1 (es) | 2012-08-17 | 2015-03-25 | Teva Pharma | Formulaciones parenterales de rasagilina |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3201470A (en) * | 1965-08-17 | Chsx c cech | ||
| US3253037A (en) * | 1962-06-19 | 1966-05-24 | Ciba Geigy Corp | N-2-alkynyl-amino-benzocylo-alkanes |
| GB1187017A (en) * | 1966-07-16 | 1970-04-08 | Aspro Nicholas Ltd | Substituted 1-Amino Indanes and Tetrahydronaphthalens |
| GB1033686A (en) * | 1965-05-10 | 1966-06-22 | Maximilian Heller | Improvements in convertible double bed settees |
| HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
| HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
| IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
-
1991
- 1991-10-16 IL IL99759A patent/IL99759A/xx not_active IP Right Cessation
- 1991-10-16 IL IL11281991A patent/IL112819A/en not_active IP Right Cessation
-
1992
- 1992-09-30 AU AU26063/92A patent/AU649565B2/en not_active Ceased
- 1992-10-01 ZA ZA927570A patent/ZA927570B/xx unknown
- 1992-10-02 FI FI924458A patent/FI113262B/fi active
- 1992-10-05 NZ NZ244616A patent/NZ244616A/en not_active IP Right Cessation
- 1992-10-06 CA CA002079968A patent/CA2079968C/en not_active Expired - Fee Related
- 1992-10-06 HU HU9203162A patent/HU217589B/hu not_active IP Right Cessation
- 1992-10-14 CN CN92113070A patent/CN1038928C/zh not_active Expired - Fee Related
- 1992-10-15 DE DE69218101T patent/DE69218101T2/de not_active Expired - Fee Related
- 1992-10-15 EP EP92402821A patent/EP0538134B1/de not_active Expired - Lifetime
- 1992-10-15 ES ES92402821T patent/ES2101063T3/es not_active Expired - Lifetime
- 1992-10-15 JP JP27731492A patent/JP3247165B2/ja not_active Expired - Fee Related
- 1992-10-15 DK DK92402821.0T patent/DK0538134T3/da active
- 1992-10-15 AT AT92402821T patent/ATE149999T1/de not_active IP Right Cessation
-
1994
- 1994-09-22 US US08/310,480 patent/US5486541A/en not_active Expired - Lifetime
-
1997
- 1997-05-26 GR GR970401207T patent/GR3023556T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ244616A (en) | 1995-04-27 |
| IL99759A0 (en) | 1992-08-18 |
| GR3023556T3 (en) | 1997-08-29 |
| EP0538134B1 (de) | 1997-03-12 |
| FI924458A0 (fi) | 1992-10-02 |
| AU2606392A (en) | 1993-04-22 |
| AU649565B2 (en) | 1994-05-26 |
| HUT67218A (en) | 1995-03-28 |
| JPH05262701A (ja) | 1993-10-12 |
| DE69218101D1 (de) | 1997-04-17 |
| FI113262B (fi) | 2004-03-31 |
| HU217589B (hu) | 2000-02-28 |
| JP3247165B2 (ja) | 2002-01-15 |
| US5486541A (en) | 1996-01-23 |
| CA2079968C (en) | 2004-12-21 |
| IL112819A (en) | 2001-11-25 |
| DE69218101T2 (de) | 1997-09-25 |
| HU9203162D0 (en) | 1992-12-28 |
| ZA927570B (en) | 1993-04-14 |
| CN1073427A (zh) | 1993-06-23 |
| EP0538134A3 (en) | 1993-06-16 |
| ES2101063T3 (es) | 1997-07-01 |
| DK0538134T3 (da) | 1997-04-01 |
| CN1038928C (zh) | 1998-07-01 |
| ATE149999T1 (de) | 1997-03-15 |
| EP0538134A2 (de) | 1993-04-21 |
| CA2079968A1 (en) | 1993-04-17 |
| FI924458L (fi) | 1993-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU673893B2 (en) | New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them | |
| AU3544593A (en) | New naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them | |
| AU1608692A (en) | Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants | |
| IL112622A0 (en) | Camptothecin derivatives, their preparation and pharmaceutical compositions containing them | |
| HU9600360D0 (en) | New bis-naphthalimides for the treatment of cancer | |
| TW252979B (de) | ||
| AU654300B2 (en) | 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation | |
| AU3559793A (en) | New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them | |
| GR3017348T3 (en) | Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. | |
| IL100955A (en) | Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| GR3017599T3 (en) | Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them. | |
| AU6970394A (en) | Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2 | |
| HK27096A (en) | Benzofuranylimidazole derivatives | |
| IL114646A0 (en) | Method of inhibiting leukotriene biosynthesis | |
| AU659738B2 (en) | New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| ES2027507A6 (es) | Procedimiento de preparacion de derivados selenofenicos. | |
| AU5511394A (en) | New (cyclohexyl)alkene compounds, processes for preparing them and pharmaceutical compositions containing them | |
| AU4965593A (en) | Ureido-acetamide derivatives, preparation thereof and drugs containing same | |
| HU9401159D0 (en) | New compound leustroducsin h, its preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |